[HTML version][PDF version][CIF][3d view][Structure Factors][CIF check Report][Issue contents]  [Buy article online]

[Contents scheme]

Acta Cryst. (2006). E62, m492-m495  [ doi:10.1107/S1600536806004636 ]

[mu]-Oxo-bis[(diethyl 6,17-dimethyldibenzo[a,h]-5,9,14,18-tetraaza[14]annulene-7,16-dicarboxylato)iron(III)] sesquihydrate

E.-G. Jäger, J. Knaudt and W. Imhof

Abstract: The title compound (systematic name: [mu]-oxo-bis{[4,15-bis(ethoxycarbonyl)-5,14-dimethyl-2,7,13,17-tetraazatricyclo[16.4.0.07,12]docosa-3,5,7,9,11,13,15,18(1),19,21-decaene-2,17-diido]iron(III)} sesquihydrate), [Fe2(C26H26N4O4)O]·1.5H2O, crystallizes in the monoclinic space group C2/c and has two iron centres which are coordinated by macrocyclic ligands with an N4 donor set. These iron centres are bridged by a [mu]-oxo ligand, resulting in the formation of a dinuclear complex unit. The [mu]-oxo ligand interacts with a water molecule via strong hydrogen bonds. These solvent molecules aggregate by additional hydrogen bonds, producing a tetranuclear aggregate. Towards the outer rim of the cavity formed by the carboxyethyl substituents attached to the tetraaza-annulene systems there are additional solvent molecules. Due to much weaker hydrogen-bond interactions, the latter are disordered and have site-occupancy factors less than 1.

Online 15 February 2006


Copyright © International Union of Crystallography
IUCr Webmaster